Cero Therapeutics Holdings CERO
OTC CERO
$0.00 0.00 (-19.61%)
As of: Oct 23, 2026 · 12:24 PM EDT

Cero Therapeutics Holdings (CERO) Return on Capital Employed [ROCE] (2023)

Updated

Cero Therapeutics Holdings (CERO) recorded Return on Capital Employed [ROCE] of -228.14% in Q4 2023, down 109.88 percentage points from the prior quarter.

Analysis

Cero Therapeutics Holdings (CERO) Return on Capital Employed [ROCE] (2023) Analysis & Trends

For FY2023, Cero Therapeutics Holdings reported Return on Capital Employed [ROCE] of -37.92%, down 34.31 percentage points from FY2022.

  • Across earlier years, Return on Capital Employed [ROCE] came in at -3.61% in FY2022.
  • Per Business Quant, the preceding three quarters came in at -118.26% (Q3 2023), -70.76% (Q2 2023) and -19.67% (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 17.52%
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn 17.92%
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn 6.28%
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 16.76%
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Cero Therapeutics Holdings 210,875.10 -5.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -228.14%
Sep 30, 2023 -118.26%
Jun 30, 2023 -70.76%
Mar 31, 2023 -19.67%
API Access

Cero Therapeutics Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CERO&period=max&api_key=YOUR_API_KEY